Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,950 | Dovepress* | 9,760+ | 1,344 | 11,104 | |
PubMed Central* | 1,190 | 460 | 1,650 | ||
Totals | 10,950 | 1,804 | 12,754 | ||
*Since 30 November 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 1 | 1 | 4 |
View citations on PubMed and Google Scholar